Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis (Q28472043)

1

0 references

Susan Cleary

2

0 references

Michael Hislop

3

0 references

Alistair Davidse

4

0 references

Leon Regensberg

5

0 references

Francesca Little

Creative Commons Attribution 4.0 International

6

0 references

language of work or name

English

0 references

publication date

December 2009

0 references

published in

PLOS MEDICINE

0 references

volume

6

0 references

issue

12

0 references

page(s)

e1000189

0 references

copyright license

start time

1 December 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Effect of pulmonary tuberculosis on mortality in patients receiving HAART.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

Healthcare utilization of patients accessing an African national treatment program

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

The direct costs of HIV/AIDS care

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

A comparison of multivariable regression models to analyse cost data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

The cost of HIV/AIDS to businesses in southern Africa.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

Aid for AIDS: an innovative solution?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

Estimating the national cost of treating people with HIV disease: patient, payer, and provider data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

How should cost data in pragmatic randomised trials be analysed?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2777319

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

29 September 2017

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000189

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000189

Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000189

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000189

Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1000189

Free dispensing of antiretroviral treatments in Africa

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19956658

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Evolving Cost of HIV in South Africa

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19956658

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cost of AIDS care in Mexico: what are its main individual predictors?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19956658